<VariationArchive VariationID="428676" VariationName="NM_000321.3(RB1):c.2520+3_2520+6del" VariationType="Deletion" Accession="VCV000428676" Version="14" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-23" DateCreated="2017-12-19" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="420586" VariationID="428676">
      <GeneList>
        <Gene Symbol="RB1" FullName="RB transcriptional corepressor 1" GeneID="5925" HGNC_ID="HGNC:9884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48303751" stop="48481890" display_start="48303751" display_stop="48481890" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48877882" stop="49056025" display_start="48877882" display_stop="49056025" Strand="+" />
          </Location>
          <OMIM>614041</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000321.3(RB1):c.2520+3_2520+6del</Name>
      <CanonicalSPDI>NC_000013.11:48473390:GTGAGT:GT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48473391" stop="48473394" display_start="48473391" display_stop="48473394" variantLength="4" positionVCF="48473390" referenceAlleleVCF="GGTGA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="49047527" stop="49047530" display_start="49047527" display_stop="49047530" variantLength="4" positionVCF="49047526" referenceAlleleVCF="GGTGA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.49047529_49047532del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.49047529_49047532del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.48473393_48473396del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.48473393_48473396del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009009.1" sequenceAccession="NG_009009" sequenceVersion="1" change="g.174647_174650del">
            <Expression>NG_009009.1:g.174647_174650del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000321.3" sequenceAccession="NM_000321" sequenceVersion="3" change="c.2520+3_2520+6del" MANESelect="true">
            <Expression>NM_000321.3:c.2520+3_2520+6del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_517" sequenceAccession="LRG_517">
            <Expression>LRG_517:g.174647_174650del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_517t1" sequenceAccession="LRG_517t1">
            <Expression>LRG_517t1:c.2520+3_2520+6del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000321.2" sequenceAccession="NM_000321" sequenceVersion="2" change="c.2520+3_2520+6delGAGT">
            <Expression>NM_000321.2:c.2520+3_2520+6delGAGT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645369528" DB="ClinGen" />
        <XRef Type="rs" ID="1131690858" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000321.3(RB1):c.2520+3_2520+6del AND Hereditary cancer-predisposing syndrome" Accession="RCV000492728" Version="4">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000321.3(RB1):c.2520+3_2520+6del AND Retinoblastoma" Accession="RCV001202042" Version="6">
        <ClassifiedConditionList TraitSetID="3557">
          <ClassifiedCondition DB="MedGen" ID="C0035335">Retinoblastoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-05-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000321.3(RB1):c.2520+3_2520+6del AND Hereditary retinoblastoma" Accession="RCV002466520" Version="1">
        <ClassifiedConditionList TraitSetID="52805">
          <ClassifiedCondition DB="MedGen" ID="C0751483">Hereditary retinoblastoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-06-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000321.3(RB1):c.2520+3_2520+6del AND not provided" Accession="RCV004591438" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-05-20" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-12-19" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12541220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18449911</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25754945</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7881418</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8346255</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8605116</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <DescriptionHistory Dated="2024-07-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6463" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinoblastoma</ElementValue>
                <XRef ID="2161" DB="GeneTests" />
                <XRef ID="Retinoblastoma/6282" DB="Genetic Alliance" />
                <XRef ID="HP:0009919" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008380" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eye cancer, retinoblastoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RETINOBLASTOMA, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="614041.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0007" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RB</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RB1</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors.</Attribute>
                <XRef ID="NBK1452" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7563" />
                <XRef ID="7563" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518780" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500594" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324949" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500108" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501237" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502581" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000333054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502480" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502479" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Both sporadic and heritable forms are tested.</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301625</ID>
                <ID Source="BookShelf">NBK1452</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 1995">
                <ID Source="pmc">1801355</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">3061998</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 2015">
                <ID Source="PubMed">26140447</ID>
                <ID Source="pmc">4570999</ID>
              </Citation>
              <XRef ID="790" DB="Orphanet" />
              <XRef ID="C0035335" DB="MedGen" />
              <XRef ID="D012175" DB="MeSH" />
              <XRef ID="MONDO:0008380" DB="MONDO" />
              <XRef Type="MIM" ID="180200" DB="OMIM" />
              <XRef Type="primary" ID="HP:0009919" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52805" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43737" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary retinoblastoma</ElementValue>
                <XRef ID="MONDO:0018160" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17544" />
                <XRef ID="17544" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="357027" DB="Orphanet" />
              <XRef ID="C0751483" DB="MedGen" />
              <XRef ID="MONDO:0018160" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5403527" SubmissionDate="2022-12-14" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="sa_pathology/familial_cancer_frome_rd/vc14152" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002761715" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_1902</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.2:c.2520+3_2520+6delGAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0018160" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_37</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2707854" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4914667|MedGen:C0035335" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001373139" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7881418</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8605116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25754945</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Comment>This sequence change falls in intron 24 of the RB1 gene. It does not directly change the encoded amino acid sequence of the RB1 protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with retinoblastoma (PMID: 7881418, 8605116, 25754945). In at least one individual the variant was observed to be de novo. This variant is also known as IVS24+3del4. ClinVar contains an entry for this variant (Variation ID: 428676). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.49047527_49047530del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0035335" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1131811" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2017-07-01">
        <ClinVarSubmissionID localKey="a88599|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000580787" DateUpdated="2024-05-01" DateCreated="2017-07-01" Type="SCV" Version="6" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12541220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18449911</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25754945</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7881418</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8346255</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8605116</ID>
          </Citation>
          <Comment>The c.2520+3_2520+6delGAGT intronic pathogenic mutation, located in intron 24 of the RB1 gene, results from a deletion of 4 nucleotides within intron 24 of the RB1 gene. This pathogenic mutation has been reported in the germline of multiple individuals diagnosed with sporadic or hereditary retinoblastoma (RB) (Ambry internal data; Lohmann DR et al. Hum. Mol. Genet. 1994 Dec;3:2187-93; Liu Z et al. Genes Chromosomes Cancer. 1995 Dec;14:277-84; Sagi M et al. Fam. Cancer. 2015 Sep;14:471-80). This pathogenic mutation has also been detected in the tumor of an individual with unilateral RB (Hogg A et al. Proc. Natl. Acad. Sci. U.S.A. 1993 Aug;90:7351-5). In addition this mutation leads to the skipping of exon 24 (Ambry internal data; Houdayer et al. Hum Mutat. 2008;29(7):975-82). Of note, this alteration is also designated as g.170405del4 and IVS24+3del4 in published literature. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.2:c.2520+3_2520+6delGAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9794927" SubmissionDate="2024-05-29" DateLastUpdated="2024-06-02" DateCreated="2024-06-02">
        <ClinVarSubmissionID localKey="NM_000321.3:c.2520+3_2520+6del|OMIM:180200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005046343" DateUpdated="2024-06-02" DateCreated="2024-06-02" Type="SCV" Version="1" SubmitterName="Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine" OrgID="1224" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-05-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Case and Pedigree Information: BILATERAL CASES:4, UNILATERAL CASES:0, TOTAL CASES:4, PEDIGREES:4. ACMG Codes Applied:PM2, PS4SUP</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000321.3:c.2520+3_2520+6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="180200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>RB12024</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9862911" SubmissionDate="2024-07-17" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="GDXSV:484159" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005079600" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on splicing and patient-derived cDNA analysis indicates skipping of exon 24 (Houdayer et al., 2008); This variant is associated with the following publications: (PMID: 8346255, 12541220, 18449911, 34247193, 7881418, 34277001, 8605116, 25754945, 24249257, 37602348)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="13" alternateAllele="-" referenceAllele="GAGT" start="49047529" stop="49047532" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:650538</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_313_20240717054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2707854" TraitType="Disease" MappingType="XRef" MappingValue="C0035335" MappingRef="MedGen">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9862911" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1131811" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9794927" TraitType="Disease" MappingType="XRef" MappingValue="180200" MappingRef="OMIM">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5403527" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0018160" MappingRef="MONDO">
        <MedGen CUI="C0751483" Name="Hereditary retinoblastoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

